U.S. Health Systems Advance Precision Medicine with Genetic Testing and AI Integration
Precision medicine is becoming mainstream in U.S. health systems, with over 76% of surveyed organizations implementing formal programs. This shift from isolated tests to organized institutional programs is driven by advancements in genetic testing and AI integration. Despite high adoption rates, challenges such as reimbursement uncertainty, high costs, and operational complexity persist. AI and advanced analytics are crucial in scaling precision medicine, particularly in clinical decision support and diagnostics. The focus is on areas with strong clinical actionability, such as oncology, pharmacogenomics, and maternal-fetal health. 
